Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Kontafarma China Holdings Ltd ( (HK:1312) ) has shared an announcement.
Kontafarma China Holdings Ltd has announced the terms of reference for its Nomination Committee, which will consist of at least three members, primarily independent non-executive directors, with a focus on gender diversity. The committee is tasked with reviewing the board’s structure and composition, assessing the independence of directors, and making recommendations on board appointments and succession planning, thereby enhancing corporate governance and aligning with the company’s strategic objectives.
More about Kontafarma China Holdings Ltd
Average Trading Volume: 1,051,304
Technical Sentiment Signal: Sell
Current Market Cap: HK$156.2M
For a thorough assessment of 1312 stock, go to TipRanks’ Stock Analysis page.